Syngenis joins WA research heavyweights in RNA medicine push
Full story
Syngenis Labs has partnered with two major medical research organizations in Western Australia. The collaboration focuses on advancing RNA medicines for rare diseases. This move creates new opportunities for manufacturing and testing. These developments occur before the company makes its debut on the ASX.
Syngenis Labs has teamed up with two of WA’s medical research giants to advance rare-disease RNA medicines, opening new testing and manufacturing opportunities ahead of its ASX debut.